Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00234221 · ClinicalTrials.gov registry record · NA
Project Health Link: Connecting Patients With Services
A NA study of Alcohol Abuse, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 686
- Enrollment target
- 1
- Study location
NCT00234221: Completed NA study of Alcohol Abuse, sponsored by University of Michigan.
NCT00234221 is a NA study of Alcohol Abuse that has completed, run by University of Michigan. The registered enrollment target is 686 participants, roughly in line with the 698-participant average among 46 other Alcohol Abuse trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00234221, a NA study of Alcohol Abuse, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 686 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare three alternative interventions in the emergency department (ED) to promote substance abuse assessment, referral, and treatment entry: 1) a 5 session strengths-based case management model (SBCM); 2) a 2-session motivational enhancement therapy (MET); or 3) a one-time brief informational feedback (BIF) session. The primary outcome variables for this trial include follow-through on receiving an assessment and referral, and treatment engagement. Additional outcomes include degree of treatment completion, alcohol-related measures, health service utilization, health status changes, and psychosocial factors.
Conditions Studied
Interventions
- BEHAVIORAL Motivational Enhancement Therapy
- BEHAVIORAL Strengths Based Case Management
- BEHAVIORAL Brief Informational Feedback
Study Locations (1)
Michigan
- Hurley Medical Center - Flint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 686 participants |
| Start Date | 2005-11 |
| Est. Completion | 2009-12 |
| Phase | NA |
What the finished NCT00234221 record still lists
NCT00234221 is an interventional study that assigns participants to a tested intervention. The registered 686 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 698-participant average among 46 other Alcohol Abuse trials with a reported enrollment target.
The record links to 1 condition, with Alcohol Abuse appearing as the primary indexed condition, and to 3 interventions - of which Motivational Enhancement Therapy is the first listed.
NCT00234221 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00234221 about?
NCT00234221 is a clinical study titled "Project Health Link: Connecting Patients With Services". This study will compare three alternative interventions in the emergency department (ED) to promote substance abuse assessment, referral, and treatment entry: 1) a 5 session strengths-based case management model (SBCM); 2) a 2-session motivational enhancement therapy (MET); or 3) a one-time brief in...
What is the current status of trial NCT00234221?
This trial is currently completed. It is a NA study. The enrollment target is 686 participants. The study started on 2005-11. Estimated completion is 2009-12.
What conditions does trial NCT00234221 study?
This clinical trial studies the following conditions: Alcohol Abuse.
What interventions are being tested in trial NCT00234221?
The interventions under investigation include: Motivational Enhancement Therapy (BEHAVIORAL), Strengths Based Case Management (BEHAVIORAL), Brief Informational Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT00234221?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00234221 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00234221's enrollment target sits among peer trials
686 7th of 46 higher than 40 of 46 other Alcohol Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
RECRUITING · NA
-
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04333537 · 686 participants · Phase 2
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- NCT06459180 · 686 participants · Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
- NCT06618274 · 686 participants · NA
Effectiveness of Central Oncology Navigation and the Use of an ORN
- NCT06899126 · 686 participants · Phase 3
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia